Boehringer Ingelheim Vetmedica GmbH

This decision concerns an application for registration of a trade mark by Boehringer Ingelheim Vetmedica GmbH. The application was opposed on the grounds that the trade mark was not capable of distinguishing the applicant's goods from the goods of other persons, and that the trade mark was likely to deceive or cause confusion. The hearing officer, Alison Windsor, was required to determine whether these grounds of opposition were made out.

The primary legal issue was whether the proposed trade mark, which included the term "quinoline derivatives," was inherently capable of distinguishing the applicant's goods and services. The opponent argued that the term "quinoline derivatives" was descriptive of a class of chemical compounds and therefore could not function as a trade mark. The hearing officer considered the evidence regarding the common usage and understanding of the term "quinoline derivatives" within the relevant industry.

The hearing officer found that the connotation of "quinoline derivatives" was not a strong connotation within the trade mark, if it existed at all. Consequently, the ground for rejection under section 43 of the relevant legislation was not considered viable. The hearing officer concluded that the application for registration should be accepted. The application was therefore accepted for possible registration.